U.S. RESEARCH ROUNDUP-Apple, EverQuote, UnitedHealth

Reuters12-26 21:03

U.S. RESEARCH ROUNDUP-Apple, EverQuote, UnitedHealth

Dec 26 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Apple, EverQuote and UnitedHealth on Thursday.

HIGHLIGHTS

* Apple Inc AAPL.O: Wedbush raises target price to $325 from $300

* EverQuote Inc EVER.O: Raymond James raises to strong buy from outperform

* Progressive Corp PGR.N: Raymond James raises to outperform from market perform

* Rapt Therapeutics Inc RAPT.O: H.C. Wainwright raises to buy from neutral

* UnitedHealth UNH.N: Raymond James adds stock to its analyst current favorites list

Following is a summary of research actions on U.S. companies reported by Reuters on Thursday. Stock entries are in alphabetical order.

* ACV Auctions Inc ACVA.O: Needham raises target price to $28 from $26

* Anavex Life Sciences Corp AVXL.O: H.C. Wainwright raises target price to $42 from $40

* Apple Inc AAPL.O: Wedbush raises target price to $325 from $300

* EverQuote Inc EVER.O: Raymond James raises to strong buy from outperform

* Hagerty Inc HGTY.N: Raymond James cuts to underperform from market perform

* Kemper Corp KMPR.N: Raymond James raises target price to $82 from $75

* Palvella Therapeutics Inc. PVLA.O: H.C. Wainwright initiates coverage with buy rating

* Progressive Corp PGR.N: Raymond James raises to outperform from market perform

* Rapt Therapeutics Inc RAPT.O: H.C. Wainwright raises to buy from neutral

* Surgery Partners Inc SGRY.O: Benchmark cuts target price to $40 from $50

* UnitedHealth UNH.N: Raymond James adds stock to its analyst current favorites list

(Compiled by Bengaluru Newsroom)

((Diaries@thomsonreuters.com))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2494857422?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-12-26 21:03","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2494857422","market":"us","top_or_hot":-1,"title":"U.S. RESEARCH ROUNDUP-Apple, EverQuote, UnitedHealth","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>U.S. RESEARCH ROUNDUP-Apple, EverQuote, UnitedHealth</title></head><body><p><span>Dec 26 (Reuters)</span><span> - </span>Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Apple, EverQuote and UnitedHealth on Thursday. </p><p>  HIGHLIGHTS </p><table><tbody><tr><td><p>* Apple Inc <span>AAPL.O</span>: Wedbush raises target price to $325 from $300</p></td></tr><tr><td><p>* EverQuote Inc <span>EVER.O</span>: Raymond James raises to strong buy from outperform</p></td></tr><tr><td><p>* Progressive Corp <span>PGR.N</span>: Raymond James raises to outperform from market perform</p></td></tr><tr><td><p>* Rapt <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> Inc <span>RAPT.O</span>: H<a href=\"https://laohu8.com/S/02403\">.C</a>. Wainwright raises to buy from neutral</p></td></tr><tr><td><p>* UnitedHealth <span>UNH.N</span>: Raymond James adds stock to its analyst current favorites list</p></td></tr></tbody></table><p>Following is a summary of research actions on U.S. companies reported by Reuters on Thursday. Stock entries are in alphabetical order.</p><table><tbody><tr><td><p>* ACV Auctions Inc <span>ACVA.O</span>: Needham raises target price to $28 from $26</p></td></tr><tr><td><p>* Anavex Life Sciences Corp <span>AVXL.O</span>: H.C. Wainwright raises target price to $42 from $40</p></td></tr><tr><td><p>* Apple Inc <span>AAPL.O</span>: Wedbush raises target price to $325 from $300</p></td></tr><tr><td><p>* EverQuote Inc <span>EVER.O</span>: Raymond James raises to strong buy from outperform</p></td></tr><tr><td><p>* <a href=\"https://laohu8.com/S/HGTY\">Hagerty</a> Inc <span>HGTY.N</span>: Raymond James cuts to underperform from market perform</p></td></tr><tr><td><p>* <a href=\"https://laohu8.com/S/KMPB\">Kemper Corp</a> <span>KMPR.N</span>: Raymond James raises target price to $82 from $75</p></td></tr><tr><td><p>* <a href=\"https://laohu8.com/S/PVLA\">Palvella Therapeutics</a> Inc. <span>PVLA.O</span>: H.C. Wainwright initiates coverage with buy rating</p></td></tr><tr><td><p>* Progressive Corp <span>PGR.N</span>: Raymond James raises to outperform from market perform</p></td></tr><tr><td><p>* Rapt Therapeutics Inc <span>RAPT.O</span>: H.C. Wainwright raises to buy from neutral</p></td></tr><tr><td><p>* Surgery Partners Inc <span>SGRY.O</span>: Benchmark cuts target price to $40 from $50</p></td></tr><tr><td><p>* UnitedHealth <span>UNH.N</span>: Raymond James adds stock to its analyst current favorites list</p></td></tr></tbody></table><p> (Compiled by Bengaluru Newsroom)</p><p> ((Diaries@thomsonreuters.com))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>U.S. RESEARCH ROUNDUP-Apple, EverQuote, UnitedHealth</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nU.S. RESEARCH ROUNDUP-Apple, EverQuote, UnitedHealth\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-12-26 21:03 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241226:nL4N3NR0HZ:1><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>U.S. RESEARCH ROUNDUP-Apple, EverQuote, UnitedHealthDec 26 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Apple, ...</p>\n\n<a href=\"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241226:nL4N3NR0HZ:1\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ACVA","symbol_name":"ACV Auctions Inc.","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241226:nL4N3NR0HZ:1","article_id":"2494857422","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2494857422","pubTimestamp":1735218219,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"U.S. RESEARCH ROUNDUP-Apple, EverQuote, UnitedHealthDec 26 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Apple, EverQu","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"ACVA":"ACV Auctions Inc.","RAPT":"RAPT Therapeutics, Inc.","LU1061106388.HKD":"BGF WORLD HEALTHSCIENCE \"A2\" (HKDHDG) ACC","IE00BZ1G4Q59.USD":"LEGG MASON CLEARBRIDGE US EQUITY SUSTAINABILITY LEADER \"A\"(USD) INC (A)","BK4550":"红杉资本持仓","BK4588":"碎股","LU0345770308.USD":"NINETY ONE GSF GLOBAL STRATEGIC EQUITY \"A\" (USD) ACC","KMPR":"Kemper Corp","SG9999018857.SGD":"United Global Quality Growth Fd Cl Acc SGD-H","SG9999001424.SGD":"United E-Commerce Fund SGD","LU0320765059.SGD":"FTIF - Franklin US Opportunities A Acc SGD","BK4574":"无人驾驶","LU1206712785.SGD":"Aviva Investors - Multi-Strategy Target Return Ah SGD","LU0784385170.HKD":"BGF GLOBAL MULTI ASSET INCOME \"A6\" (HKDHGD) INC","LU1267930573.SGD":"TEMPLETON GLOBAL \"AA\" (SGD) ACC A","LU0788109477.HKD":"BGF GLOBAL ALLOCATION \"A2\" (HKDHGD) ACC","IE0003U64NQ7.SGD":"PIMCO BALANCED INCOME AND GROWTH \"M\" (SGDHDG) ACC","LU1003077747.HKD":"BGF GLOBAL EQUITY INCOME \"A6\" (HKDHDG) INC","LU0823434583.USD":"BNP PARIBAS US GROWTH \"C\" (USD) ACC","SGXZ31699556.SGD":"UGDP UNITED GLOBAL QUALITY GROWTH \"C\" (SGDHDG) ACC","LU1267930490.SGD":"TEMPLETON GLOBAL EQUITY INCOME \"AS\" (SGD) INC A","SG9999015341.SGD":"United Income Focus Trust Acc SGD-H","AVXL":"Anavex Life Sciences Corp.","LU0708994859.HKD":"TEMPLETON GLOBAL \"A\" (HKD) ACC","UNH":"联合健康","SG9999014542.SGD":"United Income Focus Trust Acc SGD","HK0000320223.HKD":"TAIKANG KAITAI CHINA NEW OPPORTUNITIES FUND \"A\" (HKD) ACC","IE00BZ9MQY76.HKD":"FTGF CLEARBRIDGE US AGGRESSIVE GROWTH \"A\" (HKD) ACC","PVLA":"Palvella Therapeutics","BK4185":"保健护理机构","SG9999000418.SGD":"Aberdeen Standard Global Technology SGD","LU2458330169.SGD":"FRANKLIN SHARIAH TECHNOLOGY \"A\" (SGD) ACC","AAPL":"苹果","LU0957808578.USD":"THREADNEEDLE (LUX) GLOBAL TECHNOLOGY \"ZU\" (USD) ACC","HGTY":"Hagerty","LU0417517546.SGD":"Allianz US Equity Cl AT Acc SGD","LU1506573853.SGD":"MANULIFE GF GLOBAL EQUITY \"AA\" (SGD) INC","LU0642271901.SGD":"Janus Henderson Horizon Global Technology Leaders A2 SGD-H","LU1066051811.HKD":"HSBC GIF GLOBAL EQUITY VOLATILITY FOCUSED \"AM2\" (HKD) INC","LU0731783048.USD":"FIDELITY GLOBAL DIVIDEND \"A\" (USD) INC MONTHLY (G)","LU1509826696.USD":"FIDELITY GLOBAL DIVIDEND \"A\" (USD) INC B","LU0545039389.USD":"BGF GLOBAL EQUITY INCOME \"A2\" ACC","LU1868837300.USD":"CT (LUX) I AMERICAN FUND \"9\" (USD) ACC","PGR":"美国前进保险公司","LU1153585028.USD":"BGF GLOBAL LONG-HORIZON EQUITY  \"A4\" (USD) INC","SGRY":"Surgery Partners, Inc.","SG9999011175.SGD":"Nikko AM Global Dividend Equity Dis SGD-H","EVER":"Everquote Inc.","HK0000306701.USD":"TAIKANG KAITAI CHINA NEW OPPORTUNITIES FUND \"A\" (USD) INC","MACW.SI":"APPLE 3xLongSG261006"},"translate_title":"美国研究综述-苹果、EverQuote、联合健康","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ACVA":0.9,"UNH":0.9,"SGRY":0.9,"RAPT":0.9,"PVLA":0.9,"PGR":0.9,"KMPR":0.9,"HGTY":0.9,"AAPL":0.9,"EVER":0.9,"AVXL":0.9,"MACW.SI":0.6},"content_text":"U.S. RESEARCH ROUNDUP-Apple, EverQuote, UnitedHealthDec 26 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Apple, EverQuote and UnitedHealth on Thursday.   HIGHLIGHTS * Apple Inc AAPL.O: Wedbush raises target price to $325 from $300* EverQuote Inc EVER.O: Raymond James raises to strong buy from outperform* Progressive Corp PGR.N: Raymond James raises to outperform from market perform* Rapt Therapeutics Inc RAPT.O: H.C. Wainwright raises to buy from neutral* UnitedHealth UNH.N: Raymond James adds stock to its analyst current favorites listFollowing is a summary of research actions on U.S. companies reported by Reuters on Thursday. Stock entries are in alphabetical order.* ACV Auctions Inc ACVA.O: Needham raises target price to $28 from $26* Anavex Life Sciences Corp AVXL.O: H.C. Wainwright raises target price to $42 from $40* Apple Inc AAPL.O: Wedbush raises target price to $325 from $300* EverQuote Inc EVER.O: Raymond James raises to strong buy from outperform* Hagerty Inc HGTY.N: Raymond James cuts to underperform from market perform* Kemper Corp KMPR.N: Raymond James raises target price to $82 from $75* Palvella Therapeutics Inc. PVLA.O: H.C. Wainwright initiates coverage with buy rating* Progressive Corp PGR.N: Raymond James raises to outperform from market perform* Rapt Therapeutics Inc RAPT.O: H.C. Wainwright raises to buy from neutral* Surgery Partners Inc SGRY.O: Benchmark cuts target price to $40 from $50* UnitedHealth UNH.N: Raymond James adds stock to its analyst current favorites list (Compiled by Bengaluru Newsroom) ((Diaries@thomsonreuters.com))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.4","shortVersion":"4.29.4","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2494857422"}